Change Website:
Lab21 Home
Lab21 Clinical Laboratory
Lab21 Diagnostic Products
Lab21 Investor Relations
Search:
Site
Web
Home
Corporate Profile
Corporate Governance
Our Investors & Stakeholders
Corporate News & Events
Presentation Material
Technology
Email Alerts
Corporate News
Conferences & Exhibitions
Corporate News
May
15
Lab21 secures European and USA patents for HCV drug resistance genotyping
15/05/2012
May
11
Lab21 unveils new molecular analysis services at Greenville site
11/05/2012
Apr
10
Lab21 partners with top 10 IVD player to develop new Aspergillus molecular assay
10/04/2012
Mar
6
Lab21 and ITOR launch Clinical Genomics Center in USA
06/03/2012
Feb
20
Lab21 announces appointment of industry expert Fraser Logue
20/02/2012
Feb
16
Lab21 launches new lung cancer Companion Diagnostic service
16/02/2012
Jan
23
Lab21 Acquires new real time PCR technology
23/01/2012
Dec
13
Lab21 receives regulatory approval for Campylobacter assay in China
13/12/2011
Nov
29
Lab21 Ranked in Fastest Growing Technology Companies on the Deloitte Fast 500 EMEA 2011
29/11/2011
Nov
29
Lab21 Wins Biomedical Project of the Year Award
29/11/2011
Nov
9
Lab21 announces positive results for Aspergillus detection in critical care and haematology patients
09/11/2011
Oct
27
Lab21 extends CPA accreditation
27/10/2011
Sep
28
QIPP 3rd Annual Symposium: Improving Outcomes Through Innovative Partnerships
28/09/2011
Aug
5
Lab21 Contributes to Human Genetics Commission Report on Diagnostic Testing
05/08/2011
Aug
3
BD and Lab21 Collaborate to Develop Aspergillus Assay for New BD MAX™ Molecular Testing System
03/08/2011
Jul
1
Lab21 Launches HIV-1 Tropism by Genotype service for Proviral DNA
01/07/2011
Jun
27
Lab21 focuses Clinical Laboratory services
27/06/2011
May
23
Lab21 acquires molecular diagnostics company Myconostica Ltd
23/05/2011
Jan
6
Lab21 acquires Microgen Bioproducts
06/01/2011